BHVN Biohaven Ltd. Common Shares
NYSE · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$12.87
· % 处于52周区间
· 高于低点
· 至高点
$7.4852周低点
$18.5752周高点
市值 (MRQ)
$1.94B
P/E
-1.9
EPS
$-6.86
BHVN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$12.87
市值 (MRQ)
$1.94B
P/E
-1.9
EPS
$-6.86
ROE
-310.8%
52周区间
$7–$19
BHVN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
EPS$-6.862020-12-31 → 2025-12-31
自由现金流$-610M2022-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | BHVN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -1.95年均值 ≈-3.6 | ≈-3.6 | · | · | |
| 市净率 (MRQ) | 159.05年均值 ≈11.9 | ≈11.9 | 4.3 | 估值过高 | |
| 股价/自由现金流 (TTM) | -3.85年均值 ≈-5.6 | ≈-5.6 | · | · | |
| 市现率 (TTM) | -3.85年均值 ≈-5.6 | ≈-5.6 | · | · | |
| 市净率（有形资产） (MRQ) | -314.65年均值 ≈16.5 | ≈16.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | BHVN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -138.5%5年均值 ≈-125.0% | ≈-125.0% | -36.1% | 弱 | |
| ROE | -310.8%5年均值 ≈-199.1% | ≈-199.1% | -60.0% | 弱 | |
| ROIC | -1434.2%5年均值 ≈-462.6% | ≈-462.6% | -62.7% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | BHVN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 4.75年均值 ≈5.3 | ≈5.3 | 5.5 | 低流动性 | |
| Quick Ratio (速动比率) | 2.85年均值 ≈4.5 | ≈4.5 | 4.5 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-4.8%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $-0.91 | $-0.75 | -21.7% |
| 2026年3月31日 | $-0.88 | $-0.84 | -4.2% | |
| 2025年12月31日 | $-1.21 | $-1.32 | 8.0% | |
| 2025年9月30日 | $-1.64 | $-1.93 | 15.0% | |
| 2025年6月30日 | $-1.94 | $-1.93 | -0.55% | |
| 2025年3月31日 | $-2.17 | $-1.73 | -25.5% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $635M | $796M | $373M | $437M | $181M | |
| SG&A Expense | $110M | $89M | $63M | $131M | $37M | |
| Operating Expenses | $745M | $885M | $436M | $568M | $219M | |
| Operating Income | $-745M | $-885M | $-436M | $-568M | $-219M | |
| Other Non-op | $8M | $39M | $26M | $-2M | $1M | |
| Pretax Income | $-737M | $-846M | $-410M | $-570M | $-212M | |
| Income Tax | $1M | $735.0K | $-1M | $438.0K | $1M | |
| Net Income | $-739M | $-846M | $-408M | $-570M | $-214M | |
| EPS (Basic) | $-6.86 | $-9.28 | $-5.73 | $-12.75 | $-5.43 | |
| EPS (Diluted) | $-6.86 | $-9.28 | $-5.73 | $-12.75 | $-5.43 | |
| Shares (Basic) | 107,624,885 | 91,234,337 | 71,200,527 | 44,741,316 | 39,375,944 | |
| Shares (Diluted) | 107,624,885 | 91,234,337 | 71,200,527 | 44,741,316 | 39,375,944 | |
| EBITDA | $-735M | $-877M | $-429M | $-567M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $230M | $99M | $248M | $205M | $76M | |
| Short-term Investments | $89M | $387M | $133M | $260M | $0 | |
| Prepaid Expense | $47M | $49M | $35M | $21M | $7M | |
| Other Current Assets | $2M | $3M | $12M | $19M | $2M | |
| Current Assets | $368M | $538M | $442M | $587M | $95M | |
| PP&E (Net) | $16M | $17M | $17M | $18M | $13M | |
| Accum. Depreciation | $16M | $12M | $8M | $5M | $3M | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $18M | $18M | $18M | $18M | $18M | |
| Other Non-current Assets | $47M | $40M | $34M | $38M | $14M | |
| Total Assets | $451M | $615M | $513M | $662M | $142M | |
| Accounts Payable | $12M | $18M | $16M | $11M | $5M | |
| Accrued Liabilities | $104M | $51M | $40M | $44M | $37M | |
| Current Liabilities | $116M | $154M | $55M | $90M | $42M | |
| Capital Leases | $40M | $33M | $28M | $31M | $3M | |
| Other Non-current Liabilities | $5M | $5M | $2M | $2M | $3M | |
| Total Liabilities | $399M | $192M | $85M | $123M | $47M | |
| Common Stock | $1.93B | $1.66B | $888M | $616M | $0 | |
| Paid-in Capital | $194M | $112M | $40M | $14M | $0 | |
| Retained Earnings | $-2.08B | $-1.35B | $-499M | $-91M | $0 | |
| AOCI | $8M | $79.0K | $-65.0K | $284.0K | $0 | |
| Stockholders' Equity | $52M | $423M | $428M | $539M | $35M | |
| Liabilities + Equity | $451M | $615M | $513M | $662M | $142M | |
| Shares Outstanding | 132,775,113 | 101,221,989 | 81,115,723 | 68,190,479 | 0 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $10M | $8M | $7M | $1M | $1M | |
| Stock-based Comp | $112M | $72M | $29M | $194M | $66M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | $7M | $184M | $41M | $78M | · | |
| Operating Cash Flow | $-609M | $-582M | $-332M | $-298M | $-146M | |
| CapEx | $715.0K | $4M | $3M | $6M | $938.0K | |
| Investing Cash Flow | $301M | $-245M | $130M | $-305M | $944.0K | |
| Stock Issued | $189M | $666M | $243M | $284M | $0 | |
| Net Stock Activity | $189M | $666M | $243M | $284M | · | |
| Financing Cash Flow | $439M | $678M | $212M | $768M | $138M | |
| Net Change in Cash | $130M | $-150M | $10M | $166M | $-6M | |
| Taxes Paid | $133.0K | $-10M | $-33M | $38M | $17M | |
| Free Cash Flow | $-610M | $-587M | $-335M | $-304M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -138.5% | -150.0% | -69.5% | -141.9% | · | |
| ROE | -310.8% | -198.8% | -84.4% | -202.3% | · | |
| ROIC | -1434.2% | -209.2% | -101.5% | -105.5% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.5 | 8.0 | 6.5 | · | |
| Quick Ratio | 2.8 | 3.2 | 6.9 | 5.2 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $4.18 | $5.28 | $7.90 | · | |
| Cash Flow / Share | $-5.66 | $-6.38 | $-4.66 | $-6.65 | · | |
| Cash / Share | $1.73 | $0.98 | $3.06 | $3.00 | · | |
| EPS (TTM) | $-6.86 | $-9.28 | $-5.73 | $-12.75 | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-739M | $-846M | $-408M | $-570M | · | |
| Market Cap | $1.50B | $3.78B | $3.47B | $946M | · | |
| P/E | -1.6 | -4.0 | -7.5 | -1.1 | · | |
| P/B | 28.8 | 8.9 | 8.1 | 1.8 | · | |
| P / Tangible Book | 46.4 | 9.4 | 8.5 | 1.8 | · | |
| P / Cash Flow | -2.5 | -6.5 | -10.5 | -3.2 | · | |
| P / FCF | -2.5 | -6.4 | -10.4 | -3.1 | · | |
| Earnings Yield | -60.8% | -24.9% | -13.4% | -91.9% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $101M | $104M | $122M | $141M | $184M | $188M | $167M | $158M | $315M | $156M | $135M | $96M | $79M | $63M | $53M | $177M | |
| SG&A Expense | $24M | $27M | $21M | $28M | $27M | $34M | $22M | $21M | $19M | $27M | $19M | $15M | $15M | $14M | $15M | $20M | |
| Operating Expenses | $125M | $130M | $143M | $169M | $212M | $222M | $190M | $178M | $334M | $183M | $154M | $111M | $94M | $78M | $68M | $197M | |
| Operating Income | $-125M | $-130M | $-143M | $-169M | $-212M | $-222M | $-190M | $-178M | $-334M | $-183M | $-154M | $-111M | $-94M | $-78M | $-68M | $-197M | |
| Other Non-op | $-12M | $168.0K | $-2M | $-4M | $14M | $493.0K | $3M | $18M | $14M | $4M | $8M | $5M | $6M | $8M | $0 | $-67.0K | |
| Pretax Income | $-137M | $-130M | $-145M | $-173M | $-198M | $-221M | $-187M | $-160M | $-320M | $-179M | $-146M | $-106M | $-88M | $-70M | $-68M | $-197M | |
| Income Tax | $391.0K | $272.0K | $351.0K | $221.0K | $261.0K | $609.0K | $48.0K | $-59.0K | $177.0K | $569.0K | $-1M | $-3M | $2M | $939.0K | $1M | $6M | |
| Net Income | $-137M | $-131M | $-146M | $-173M | $-198M | $-222M | $-187M | $-160M | $-320M | $-180M | $-145M | $-103M | $-90M | $-70M | $-69M | $-203M | |
| EPS (Basic) | $-0.91 | $-0.88 | $-1.11 | $-1.64 | $-1.94 | $-2.17 | $-1.74 | $-1.70 | $-3.64 | $-2.20 | $-1.88 | $-1.50 | $-1.32 | $-1.03 | $-1.75 | $-5.16 | |
| EPS (Diluted) | $-0.91 | $-0.88 | $-1.11 | $-1.64 | $-1.94 | $-2.17 | $-1.74 | $-1.70 | $-3.64 | $-2.20 | $-1.88 | $-1.50 | $-1.32 | $-1.03 | $-1.75 | $-5.16 | |
| Shares (Basic) | 150,636,620 | 147,615,197 | · | 105,815,038 | 102,372,820 | 101,943,396 | · | 94,372,159 | 87,766,069 | 81,601,826 | · | 68,320,125 | 68,248,023 | 68,206,879 | 39,375,944 | 39,375,944 | |
| Shares (Diluted) | 150,636,620 | 147,615,197 | · | 105,815,038 | 102,372,820 | 101,943,396 | · | 94,372,159 | 87,766,069 | 81,601,826 | · | 68,320,125 | 68,248,023 | 68,206,879 | 39,375,944 | 39,375,944 | |
| EBITDA | $-125M | $-128M | · | $-169M | $-212M | $-219M | · | $-178M | $-334M | $-182M | · | $-111M | $-94M | $-76M | $-68M | · |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $238M | $273M | $230M | $185M | $166M | $98M | $99M | $84M | $239M | $183M | $248M | $112M | $148M | $125M | $51M | · | |
| Short-term Investments | $30M | $75M | $89M | $75M | $239M | $224M | $387M | $294M | $198M | $101M | · | $129M | $188M | $263M | · | · | |
| Prepaid Expense | $27M | $35M | $47M | $55M | $61M | $56M | $49M | $55M | $60M | $46M | · | $34M | $28M | $26M | $18M | · | |
| Other Current Assets | $2M | $3M | $2M | $8M | $8M | $4M | $3M | $1M | $7M | $11M | · | $23M | $22M | $25M | $12M | · | |
| Current Assets | $297M | $386M | $368M | $324M | $475M | $383M | $538M | $440M | $511M | $349M | · | $311M | $434M | $544M | $81M | · | |
| PP&E (Net) | $15M | $15M | $16M | $18M | $19M | $18M | $17M | $18M | $19M | $17M | · | $18M | $17M | $17M | $17M | · | |
| Accum. Depreciation | $17M | $17M | $16M | $15M | $14M | $13M | $12M | $11M | $10M | $9M | · | $7M | $6M | $6M | $5M | · | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | $1M | · | |
| Intangibles | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | · | |
| Other Non-current Assets | $39M | $46M | $47M | $48M | $37M | $39M | $40M | $32M | $33M | $33M | · | $35M | $36M | $37M | $18M | · | |
| Total Assets | $371M | $466M | $451M | $409M | $550M | $459M | $615M | $511M | $583M | $419M | · | $383M | $507M | $619M | $136M | · | |
| Accounts Payable | $12M | $10M | $12M | $17M | $20M | $19M | $18M | $20M | $17M | $36M | · | $10M | $12M | $14M | $5M | · | |
| Accrued Liabilities | $51M | $42M | $104M | $74M | $79M | $57M | $51M | $64M | $58M | $50M | · | $53M | $35M | $38M | $24M | · | |
| Current Liabilities | $63M | $52M | $116M | $113M | $124M | $164M | $154M | $152M | $156M | $87M | · | $62M | $88M | $114M | $28M | · | |
| Capital Leases | $33M | $38M | $40M | $40M | $30M | $31M | $33M | $25M | $26M | $27M | · | $28M | $29M | $30M | $4M | · | |
| Other Non-current Liabilities | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | $2M | $3M | $2M | $7M | · | |
| Total Liabilities | $359M | $337M | $399M | $426M | $416M | $199M | $192M | $195M | $199M | $117M | · | $93M | $119M | $146M | $35M | · | |
| Common Stock | $2.14B | $2.13B | $1.93B | $1.74B | $1.74B | $1.69B | $1.66B | $1.38B | $1.30B | $911M | · | $619M | $618M | $616M | · | · | |
| Paid-in Capital | $220M | $203M | $194M | $178M | $157M | $137M | $112M | $93M | $84M | $69M | · | $26M | $22M | $17M | · | · | |
| Retained Earnings | $-2.35B | $-2.22B | $-2.08B | $-1.94B | $-1.77B | $-1.57B | $-1.35B | $-1.16B | $-999M | $-679M | · | $-355M | $-252M | $-162M | · | · | |
| AOCI | $5M | $8M | $8M | $36.0K | $-3.0K | $73.0K | $79.0K | $140.0K | $-78.0K | $-106.0K | · | $158.0K | $20.0K | $166.0K | · | · | |
| Stockholders' Equity | $12M | $130M | $52M | $-17M | $135M | $259M | $423M | $316M | $384M | $301M | $428M | $290M | $387M | $472M | $100M | · | |
| Liabilities + Equity | $371M | $466M | $451M | $409M | $550M | $459M | $615M | $511M | $583M | $419M | · | $383M | $507M | $619M | $136M | · | |
| Shares Outstanding | 151,017,531 | 150,506,490 | 132,775,113 | 105,803,655 | 105,782,447 | 102,104,024 | 101,221,989 | 94,899,193 | 92,346,332 | 81,807,221 | · | 68,364,143 | 68,316,953 | 68,212,479 | 100 | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $377.0K | $415.0K | |
| Stock-based Comp | $19M | $28M | $17M | $22M | $21M | $53M | $13M | $12M | $12M | $35M | $16M | $4M | $5M | $4M | $17M | $21M | |
| Other Non-cash | · | $-50M | · | · | · | $1M | · | · | · | $41M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-85M | $-150M | $-131M | $-146M | $-168M | $-165M | $-171M | $-141M | $-168M | $-103M | $-115M | $-95M | $-44M | $-78M | $-96M | $-68M | |
| CapEx | $454.0K | $0 | $8.0K | $13.0K | $233.0K | $461.0K | $49.0K | $611.0K | $3M | $440.0K | $470.0K | $1M | $595.0K | $735.0K | $5M | $1M | |
| Investing Cash Flow | $45M | $15M | $-14M | $165M | $-16M | $165M | $-88M | $-93M | $-98M | $34M | $-4M | $59M | $76M | $-1M | $-5M | $-36M | |
| Stock Issued | $0 | $179M | $189M | $0 | $0 | $0 | $271M | $76M | · | · | $243M | $0 | · | · | · | · | |
| Net Stock Activity | · | $179M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $179M | $189M | $122.0K | $250M | $369.0K | $273M | $80M | $321M | $3M | $245M | $-40M | $-20M | $27M | $128M | $87M | |
| Net Change in Cash | $-36M | $44M | $44M | $19M | $66M | $147.0K | $15M | $-154M | $55M | $-65M | $126M | $-76M | $11M | $-52M | $27M | $-17M | |
| Free Cash Flow | · | $-150M | · | · | · | $-166M | · | · | · | $-103M | · | · | · | $-78M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -29.8% | -28.2% | · | -37.7% | -35.0% | -50.5% | · | -35.9% | -58.7% | -34.6% | · | -39.6% | -35.7% | -22.8% | -101.5% | · | |
| ROE | -187.1% | -67.1% | · | -116.1% | -76.5% | -79.0% | · | -52.9% | -83.0% | -46.4% | · | -52.6% | -46.7% | -29.8% | -137.4% | · | |
| ROIC | -1024.8% | -100.9% | · | 988.3% | -157.5% | -85.6% | · | -56.4% | -87.0% | -61.0% | · | -36.9% | -24.9% | -16.7% | -68.7% | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 7.4 | · | 2.9 | 3.8 | 2.3 | · | 2.9 | 3.3 | 4.0 | · | 5.0 | 4.9 | 4.8 | 2.8 | · | |
| Quick Ratio | 4.3 | 6.7 | · | 2.3 | 3.3 | 2.0 | · | 2.5 | 2.8 | 3.3 | · | 3.9 | 3.8 | 3.4 | 1.8 | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.86 | · | $-0.16 | $1.27 | $2.54 | · | $3.33 | $4.16 | $3.68 | · | $4.24 | $5.67 | $6.92 | $1002160.00 | · | |
| Cash Flow / Share | · | $-1.02 | · | · | · | $-1.62 | · | · | · | $-1.26 | · | · | · | $-1.14 | · | · | |
| Cash / Share | $1.58 | $1.81 | · | $1.75 | $1.57 | $0.96 | · | $0.89 | $2.59 | $2.23 | · | $1.63 | $2.16 | $1.83 | $506680.00 | · | |
| EPS (TTM) | $-4.54 | $-5.57 | · | $-7.49 | $-7.55 | $-9.25 | · | $-9.42 | $-9.22 | $-6.90 | · | $-7.23 | $-7.48 | $-11.32 | $-10.69 | $-10.32 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-587M | $-648M | · | $-780M | $-767M | $-889M | · | $-804M | $-747M | $-517M | · | $-465M | $-431M | $-544M | $-421M | $-407M | |
| Market Cap | $2.25B | $1.27B | · | $1.59B | $1.49B | $2.45B | · | $4.74B | $3.21B | $4.47B | · | $1.78B | $1.63B | $932M | $616 | · | |
| P/E | -3.3 | -1.5 | · | -2.0 | -1.9 | -2.6 | · | -5.3 | -3.8 | -7.9 | · | -3.6 | -3.2 | -1.2 | -0.6 | · | |
| P/B | 183.9 | 9.8 | · | -92.5 | 11.1 | 9.5 | · | 15.0 | 8.4 | 14.8 | · | 6.1 | 4.2 | 2.0 | 0.0 | · | |
| P / Tangible Book | · | 11.6 | · | · | 13.0 | 10.2 | · | 16.0 | 8.8 | 15.9 | · | 6.6 | 4.4 | 2.1 | 0.0 | · | |
| P / Cash Flow | · | -8.5 | · | · | · | -14.9 | · | · | · | -43.6 | · | · | · | -12.0 | · | · | |
| Earnings Yield | -30.5% | -65.8% | · | -49.9% | -53.5% | -38.5% | · | -18.9% | -26.6% | -12.6% | · | -27.8% | -31.3% | -82.9% | -173.6% | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-739M | $-846M | $-408M | $-570M | $-214M |
| 稀释后每股收益 (EPS) | $-6.86 | $-9.28 | $-5.73 | $-12.75 | $-5.43 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.2 | 3.5 | 8.0 | 6.5 | · |
| 速动比率 | 2.8 | 3.2 | 6.9 | 5.2 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-610M | $-587M | $-335M | $-304M | · |
机构持有人 (13F) 326 家申报者 · $2.3B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
326
持有价值
$2.3B
新仓位
55
已退出持仓
31
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 55 (+3 与上一季度对比) | 31 (-6 与上一季度对比) | 110 (-5 与上一季度对比) | 84 (+14 与上一季度对比) | -8.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $196573505 | 13210585 | 8.61% | 股份 |
| MONTANOVA CAPITAL, LLC | $153069623 | 10286937 | 6.71% | 股份 |
| JANUS HENDERSON GROUP PLC | $148213808 | 17534612 | 6.50% | 股份 |
| STIFEL FINANCIAL CORP | $147924530 | 9941165 | 6.48% | 股份 |
| Woodline Partners LP | $113984966 | 7660280 | 5.00% | 股份 |
| STATE STREET CORP | $103371866 | 6947034 | 4.53% | 股份 |
| INFINITUM ASSET MANAGEMENT, LLC | $93000000 | 6250000 | 4.08% | 股份 |
| RP Management, LLC | $70593628 | 2936507 | 3.09% | 股份 |
| D. E. Shaw & Co., Inc. | $62350102 | 4190195 | 2.73% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $61761159 | 4150616 | 2.71% | 股份 |
| VANGUARD GROUP INC | $49630230 | 4395946 | 2.18% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $49460273 | 3323190 | 2.17% | 股份 |
| FMR LLC | $44113698 | 2964630 | 1.93% | 股份 |
| Royalty Pharma Sub-Manager, LLC | $43695224 | 2936507 | 1.91% | 股份 |
| Cormorant Asset Management, LP | $38836800 | 2610000 | 1.70% | 股份 |
| GOLDMAN SACHS GROUP INC | $38435724 | 2583046 | 1.68% | 股份 |
| UBS Group AG | $37480146 | 2518827 | 1.64% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $37035442 | 2488941 | 1.62% | 股份 |
| Balyasny Asset Management L.P. | $27970442 | 1879734 | 1.23% | 股份 |
| TCG Crossover Management, LLC | $26485686 | 1779952 | 1.16% | 股份 |
| Nuveen, LLC | $25955690 | 1744334 | 1.14% | 股份 |
| Rubric Capital Management LP | $25615816 | 1721493 | 1.12% | 股份 |
| CITADEL ADVISORS LLC | $24100779 | 1619676 | 1.06% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $22153478 | 1488809 | 0.97% | 股份 |
| BANK OF AMERICA CORP /DE/ | $21990229 | 1477838 | 0.96% | 股份 |
| ARS Investment Partners, LLC | $20447873 | 1374185 | 0.90% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $18219399 | 1224422 | 0.80% | 股份 |
| Capital Research Global Investors | $17849230 | 1199545 | 0.78% | 股份 |
| NORTHERN TRUST CORP | $17650820 | 1186211 | 0.77% | 股份 |
| MYDA Advisors LLC | $17112000 | 1150000 | 0.75% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $16506131 | 1109283 | 0.72% | 股份 |
| STEMPOINT CAPITAL LP | $15835296 | 1064200 | 0.69% | 股份 |
| Simplify Asset Management Inc. | $15478994 | 1040255 | 0.68% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14880000 | 1000000 | 0.65% | 股份 |
| Qube Research & Technologies Ltd | $13480313 | 905935 | 0.59% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $13134933 | 882724 | 0.58% | 股份 |
| MORGAN STANLEY | $12519320 | 841351 | 0.55% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $12332232 | 828779 | 0.54% | 股份 |
| Ikarian Capital, LLC | $11132933 | 748181 | 0.49% | 股份 |
| Erste Asset Management GmbH | $11022635 | 737300 | 0.48% | 股份 |
| 5AM Venture Management, LLC | $10995903 | 738972 | 0.48% | 股份 |
| Iron Triangle Partners LP | $10819613 | 958336 | 0.47% | 股份 |
| Integral Health Asset Management, LLC | $10416000 | 700000 | 0.46% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9780624 | 657300 | 0.43% | 买入期权 |
| MARSHALL WACE, LLP | $9692074 | 651349 | 0.42% | 股份 |
| Longaeva Partners L.P. | $8926557 | 599903 | 0.39% | 股份 |
| ORACLE INVESTMENT MANAGEMENT INC | $8717923 | 772181 | 0.38% | 股份 |
| Sarissa Capital Management LP | $8664803 | 582312 | 0.38% | 股份 |
| Pfizer Inc | $8004360 | 505645 | 0.35% | 股份 |
| Eversept Partners, LP | $7675164 | 515804 | 0.34% | 股份 |
公司内部人士 13 位内幕人士 · 5 位高管 · 5 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Vlad Coric | Chief Executive Officer | 2026年2月27日 A | 1803968 | 2 | 0 | $4999996 |
| Matthew Buten | Chief Financial Officer | 2026年2月27日 A | 195652 | 0 | 0 | $0 |
| Kimberly Gentile | SVP, Clinical Operations | 2026年9月15日 A | 99557 | 0 | 0 | $0 |
| George C. Clark | VP, Chief Accounting Officer | 2026年2月27日 A | 66978 | 1 | 0 | $144840 |
| Bruce Car | Chief Scientific Officer | 2026年2月27日 A | 7715 | 0 | 0 | $0 |
| Irina Antonijevic | 董事 | 2026年4月28日 A | 2535 | 0 | 0 | $0 |
| Kishan Mehta | 董事 | 2026年4月28日 A | 17342 | 0 | 0 | $0 |
| Michael Thomas Heffernan | 董事 | 2026年4月28日 A | 15178 | 0 | 0 | $0 |
| John W Childs | 董事 | 2026年4月28日 A | 2323971 | 2 | 0 | $25864210 |
| Biohaven Pharmaceutical Holding Co Ltd. | 10% 所有者 | 2022年10月3日 J | 0 | 0 | 0 | $0 |
| Gregory H. Bailey | · | 2026年4月28日 A | 2020071 | 1 | 0 | $3000000 |
| Robert J Hugin | · | 2026年4月28日 A | 12959 | 0 | 0 | $0 |
| Julia P Gregory | · | 2026年4月28日 A | 25665 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 19 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 1.68% | 9836 SH | 2026年9月11日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.35% | 128814 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.13% | 255530 SH | 2026年10月2日 | 每日 |
| NUSC · Nushares ETF Trust | 0.13% | 120245 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.12% | 143177 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.12% | 957494 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.11% | 1252927 SH | 2026年9月11日 | 每日 |
| ESML · iShares Trust | 0.07% | 161187 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 768380 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.06% | 63802 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.06% | 3410283 SH | 2026年9月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 373567 SH | 2026年8月19日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1488809 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.01% | 7762 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 36959 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.00% | 169731 SH | 2026年9月11日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 11060 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 5941 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 28693 SH | 2026年9月11日 | 每日 |
BHVN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 23 位分析师
买入
中位数目标
$20.00
+55.4%
7 30.4%
强烈买入
11 47.8%
买入
4 17.4%
持有
1 4.3%
卖出
0 0.0%
强烈卖出
12个月价格目标
15 位分析师 · 2026-10-01平均目标 $21.27 +65.2%
现在
当前价格 $12.87
最低$10.00
平均值$21.27
最高$42.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报